subject area of
- 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. Academic Article
- Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee Academic Article
- Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis Academic Article
- Cost-effectiveness of alternative treatments for women with osteoporosis in Canada Academic Article
- Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada Academic Article
- Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study Academic Article
- Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women Academic Article
- Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis Academic Article
- III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis Academic Article
- In vitrodisintegration studies of weekly generic and branded risedronate sodium formulations available in Canada Academic Article
- Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis Academic Article
- Oral bisphosphonates Academic Article
- Osteonecrosis of the jaw: new developments in an old disease. Academic Article
- Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy Academic Article
- Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate Academic Article
- Review of the safety and efficacy of risedronate for the treatment of male osteoporosis. Academic Article
- Risedronate for the prevention and treatment of postmenopausal osteoporosis. Academic Article
- The Efficacy and Tolerability of Risedronate Once a week for the Treatment of Postmenopausal Osteoporosis Academic Article
- Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease Academic Article
- Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Academic Article
- Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data Academic Article
- [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)]. Academic Article